News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
512 Results
Type
Article (15)
Press Release (497)
Section
Business (158)
Deals (14)
Drug Development (107)
FDA (11)
Job Trends (4)
News (292)
Policy (14)
Tag
Alliances (102)
Antibody-drug conjugate (ADC) (2)
Approvals (11)
Artificial intelligence (3)
Best Places to Work (2)
Breast cancer (1)
Cancer (8)
Clinical research (97)
Collaboration (5)
Data (7)
Diagnostics (3)
Drug discovery (1)
Earnings (35)
Events (50)
FDA (11)
Funding (4)
GLP-1 (2)
Healthcare (11)
IPO (3)
Job creations (2)
JPM (1)
Legal (4)
Medical device (1)
Medtech (1)
Mergers & acquisitions (13)
NextGen: Class of 2026 (1)
Patient recruitment (2)
People (22)
Phase 1 (49)
Phase 2 (33)
Phase 3 (17)
Pipeline (4)
Postmarket research (1)
Preclinical (13)
Radiopharmaceuticals (1)
Rare diseases (1)
Regulatory (10)
Startups (3)
Date
Last 30 days (2)
Last 365 days (25)
2026 (2)
2025 (26)
2024 (33)
2023 (16)
2022 (22)
2021 (19)
2020 (19)
2019 (24)
2018 (20)
2017 (37)
2016 (17)
2015 (19)
2014 (37)
2013 (24)
2012 (35)
2011 (57)
2010 (18)
Location
Asia (21)
Australia (1)
California (2)
Canada (10)
Colorado (1)
Europe (289)
Illinois (4)
Massachusetts (10)
Southern California (1)
United States (17)
512 Results for "debiopharm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GARDP and Debiopharm Partner to Advance Development of Novel Gonorrhea Drug
January 13, 2026
·
5 min read
Press Releases
Redefining Acromegaly Care: First Patient Randomized in Debiopharm’s Phase III OXTEND-03™ Trial of 3-Month Debio 4126 Treatment
December 4, 2025
·
4 min read
Press Releases
Debiopharm Takes a Step Forward for Children With CPP: Enrollment Completion for the Phase III Trial Evaluating the First Ever Yearly Injectable Triptorelin Formulation
November 7, 2025
·
6 min read
Press Releases
Debiopharm Licenses SunRock Biopharma’s Anti-HER3/HER2 Antibody to Explore the Full Potential of Bispecific ADC Debio 2512
October 1, 2025
·
4 min read
Press Releases
Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib
July 16, 2025
·
7 min read
Press Releases
Debiopharm Pushes the Boundaries of Innovation in Antibiotic Development Against Gonorrhea with First-In-Human Debio 1453 Trial
August 27, 2025
·
6 min read
Press Releases
Debiopharm’s ADC Research Gains Momentum With Launch of First-in-human Trial Assessing Debio 1562M in Acute Myeloid Leukemia Patients
June 16, 2025
·
4 min read
Press Releases
Debiopharm and Alkyon Therapeutics Announce Research Collaboration to Advance the Next Generation of Radioligand Therapies
June 12, 2025
·
3 min read
Business
Debiopharm and Genome & Company Reach Agreement for Potential First-In Class Oncology Antibody Drug Conjugate Family
Debiopharm granted exclusive global rights to use Genome & Company’s antibodies to develop potential first-in-class ADCs integrating Debiopharm’s Multilink™ technology.
June 3, 2024
·
5 min read
Press Releases
Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research
April 24, 2025
·
3 min read
1 of 52
Next
